Logo

Biological Dynamics

Biological Dynamics Partners With Pancreatic Cancer Consortium On Early Detection Study

The firm aims to recruit at least 1,000, and up to 5,000, individuals at an elevated risk for pancreatic cancer, comparing its test to standard-of-care surveillance.

People in the News at Sophia Genetics, InformedDNA, Accelerate Diagnostics, Centogene, More

Executive and academic appointments, promotions, and departures in omics and molecular diagnostics for the week of March 6, 2023.

People in the News at Angle, Centogene, Prenetics, Biological Dynamics, Enalees

Executive appointments, promotions, and departures in omics and molecular diagnostics for the week of Jan. 16, 2023.

Biological Dynamics Taps Two Firms to Study Utility, Economics of Pancreatic Cancer Detection Test

Research companies Curta and Qure Healthcare will be conducting an economic modeling and physician behavior study, respectively.

People in the News at Biological Dynamics, Bionano Genomics, DNA Script, Pleno, NeoGenomics, More

Executive appointments, promotions, and departures in omics and molecular diagnostics for the week of Nov. 7, 2022.

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.